期刊文献+

三七皂苷对系统性红斑狼疮患者外周血淋巴细胞P-糖蛋白及激素效应的影响 被引量:12

The effects of Panax Notoginseng Saponins on P-glycoprotein and the function of glucocorticoid in lymphocytes of systemic lupus erythematosus patients
原文传递
导出
摘要 目的 探讨系统性红斑狼疮(SLE)患者糖皮质激素耐药机制以及三七皂苷逆转耐药的作用.方法 直线相关分析SLE患者外周血淋巴细胞P-糖蛋白与SLE疾病活动指数(SLEDAI)、临床疗效的相关性.用三七皂苷干预患者外周血淋巴细胞,维拉帕米为对照,流式细胞术检测淋巴细胞P-糖蛋白、罗丹明123以及联合甲泼尼龙干预的细胞凋亡率.采用方差分析或t检验进行统计学分析.结果 SLE患者外周血淋巴细胞P-糖蛋白与SLEDAI呈正相关(r=0.490,P〈0.05),缓解组P-糖蛋白(12.2±2.5)%与部分缓解或无效组(16.5±4.0)%差异有统计学意义.三七皂苷干预组P-糖蛋白(11.2±3.1)%和罗丹明123(70.1±5.8)%与对照组[分别为(15.3±2.9)%,(53.9±5.2)%]比较差异有统计学意义.三七皂苷可协同甲泼尼龙诱导淋巴细胞凋亡.结论 三七皂苷下调P-糖蛋白表达和转运活性的双重作用可能是协同甲泼尼龙诱导淋巴细胞凋亡的重要机制. Objective To investigate the mechanism of glucocorticoid resistance in patients with systemic lupus erythematosus(SLE) and the effects of Panax Notoginseng Saponins(PNS) on reversing glucocorticoid resistance in lymphocytes. Methods The relevance between P-glycoprotein (P-gp, %) and SLEDAI integrals or clinical effects was analyzed by linear correlation analysis. The lymphocytes from SLE patients were intervened with PNS or verapamil. P-gp of the lymphocytes and Rhodamine 123 (Rh123, %) accumulated in the lymphocytes were assayed by flow cytometry. The percentage of the apoptosis of the lymphocytes stimulated with PNS or verapamil combined with methylprednisolone was identified by double-tagging with Annexin V and propidium iodide (PI) and detected by flow cytometry. Variance analysis or Student's t test was used for statistics. Results The P-gp in the peripheral blood lymphocytes of SLE patients was significantly related to SLEDAI integrals. The difference of P-gp between lymphocytes in the completely remission cases (12.2±2.5)% and lymphocytes in the partial remission or non-effective cases (16.5±4.0)% was statistically significantce. The difference of P-gp and Rh123 between lymphocytes treated with PNS [(11.2±3.1)%,(70.1 ±5.8)% respectively ] and lymphocytes of the control group [ (15.3±2.9)%, (53.9±5.2)% respectively ]was statistically significant. The lymphocytes apoptosis rate in the lymphocytes stimulated with methylprednisone combined with PNS increased significantly compared to the lymphocytes stimulated with methylprednisolone only. Conclusion The action of PNS in suppressing both the expression and the transfer activity of P-gp is possibly the important mechanism to increase the effects of methylprednisolone in inducing lymphocytes apoptosis.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2011年第1期38-41,共4页 Chinese Journal of Rheumatology
基金 杭州市科技发展计划专科专项基金(2006533Q01)
关键词 皂苷类 红斑狼疮 系统性 淋巴细胞 P-糖蛋白 糖皮质激素类 Saponins Lupus erythematosus, systemic Lymphocytes P-glycoprotein Glucocorticoids
  • 相关文献

参考文献10

  • 1Tsujimura S,Saito K,Nakayamada S,et al.Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus.Arthritis Rheum,2005,52:1676-1683.
  • 2Tsujimura S,Saito K,Nawata M,et al.Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.Ann Rheum Dis,2008,67:380-388.
  • 3王彩虹,李小峰,罗静,张改连,张琳,赵向聪.类风湿关节炎改变病情抗风湿药耐药性生物学标志研究进展[J].中华风湿病学杂志,2009,13(10):708-711. 被引量:4
  • 4Webster JI,Carlstedt-Duke J.Involvement of multidrug resistance proteins (MDR) in the modulation of glucocorticoid response.J Steroid Biochem Mol Biol,2002,82:277-288.
  • 5Dilger K,Schwab M,Fromm MF.Identification of budesonide and prednisone as substrates of the intestinal drug efflux Pump P-glycoprotein.Inflamm Bowel Dis,2004,10:578-583.
  • 6Diza-Borjon A,Richaud-Patin Y,Alvarado BC,et al.Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders (Part Ⅱ):increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control.Joint Bone Spine,2000,67:40-48.
  • 7Kayo H,Masaharu Y,Noriko Y,et al.P-glycoprotein functions in peripheral-blood CD4-cells of patients with systemic lupus erythematosus.Biol Pharm Bull,2008,31:873-878.
  • 8Tsujimura S,Saito K,Nakayamada S,et al.Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes.Genes Cells,2004,9:1265-1273.
  • 9史亦谦,田同德.三七总皂甙体外逆转K562/VCR细胞多药耐药的实验研究[J].中国中医药科技,2005,12(5):292-294. 被引量:22
  • 10史曦凯,张翼军,赵春景.人参皂甙单体Rb1对多药耐药细胞系K562/HHT的耐药逆转作用[J].第三军医大学学报,1999,21(11):825-827. 被引量:55

二级参考文献33

  • 1韩俊领,严文伟,钱其军,施红,韩明哲,顾孔书,邱录贵,冯四洲.K_(562)和L_(210)耐高三尖杉酯碱细胞系的建立及其耐药机制的初步研究[J].中华医学杂志,1994,74(7):424-427. 被引量:6
  • 2Fleischmann RM. Is there a need for new therapies for rheumatoid arthritis? J Rheumatol, 2005, 73 Suppl: S3-S7.
  • 3Galindo-Rodriguez G, Avina-Zubieta JA, Russell AS, et al. Disappointing hongterm results with disease modifying antirheumatic drugs: a practice based study. J Rheumatol, 1999, 26: 2337- 2343.
  • 4Choy EH, Smith C, Dore C J, et al. A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal. Rheumatology (Oxford), 2005, 44: 1414-1421.
  • 5Nurmohamed MT, Dijkmans BA. Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis. Drugs, 2005, 65: 661-694.
  • 6Aletaha D, Smolen JS. Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis: an observational study. J Rheumatol, 2002, 29: 1631-1638.
  • 7Wollheim FA. Drug resistance in rheumatology:an area in search of investigators. Curr Rheumatol Rep, 2003, 5: 333-335.
  • 8Jansen G, Scheper RJ, Dijkmans BA. Muhidrug resistance proteins in rheumatoid arthritis, role in disease-modifying antirheumatic drug efficacy and inflammatory processes: an overview. Scand J Rheumatol, 2003, 32: 325-336.
  • 9Van der Heijden JW, Dijkmans BA, Scheper R J, et al. Drug Insight: resistance to methotrexate and other disease-modifying antirheumatie drugs-from bench to bedside. Nat Clin Pract Rheumatol, 2007, 3: 26-34.
  • 10Bohanec-Grabar P, Logar D, Lestan B, et al. Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism.Eur J Clin Pharmacol, 2008, 64: 1057-1068.

共引文献75

同被引文献199

引证文献12

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部